Alaunos Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TCRT on Nasdaq
Industry
Pharmaceutical Preparations
Location
2617 Bissonnet St, Suite 233, Houston, TX

Insiders trading volume in the past year

Alaunos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Postma Director $276K +$5.45K +2.01% Jul 3, 2025
Kevin S. Sr. Boyle Chief Executive Officer, Director $112K Sep 1, 2023
Jaime Vieser Director $106K -$4.9K -4.42% Jul 3, 2025
Raffaele Baffa Chief Medical Officer $39.4K May 17, 2021
Eleanor De Groot EVP, Operations $33.3K Mar 30, 2022
James Huang Director $26.4K Jun 6, 2023
Ferdinand Groenewald Vice President of Finance $22.6K Aug 18, 2025
Heidi Hagen Director $20.5K Sep 2, 2021
Mary Thistle Director $6.31K Jun 6, 2023
Christopher Bowden Director $6.2K Jun 22, 2022
Drew Deniger Vice President, Research and Development $2.11K Mar 15, 2023
Abhishek K. Srivastava Vice President, Technical Operations $168 Mar 15, 2023
Dale Curtis Hogue Jr. Chief Executive Officer, Interim, Director Mar 29, 2025
Robert Hofmeister Director Jun 6, 2024
Melinda Lackey Legal & Administration Mar 29, 2025
Michael Wong Vice President, Finance Mar 15, 2023
Michael Allen Jerman Director Jul 15, 2025
Holger Weis Chief Executive Officer, Director Aug 18, 2025

Recent Insider Transactions by Companies or Individuals for Alaunos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.